Goldman Agents Hologic Term Loan B Refi
Hologic announced that the company completed a refinancing of its senior secured tranche B term loan facility under the company’s credit agreement dated August 1, 2012.
On February 26, 2014, the company and several of its domestic subsidiaries, with Goldman Sachs Bank, as administrative and collateral agent, and the lenders party thereto, entered into a refinancing amendment to the credit agreement.
The amendment evidences, among other things, the refinancing of the company’s existing term loan B with a maturity date of August 1, 2019, with a new senior secured tranche B term loan facility with an issue price of 99.875% of the principal amount of the existing term loan B.
The agreement amendment will result in up to a 50 basis point reduction in the interest rate on the new term loan B as of the agreement amendment closing date (from 2.75% plus LIBOR with a 1.00% floor to 2.50% plus LIBOR with a 0.75% floor).
In addition, the company voluntarily prepaid $25 million of the new term loan B on February 26, 2014. Immediately following this prepayment, the principal amount outstanding on the new term loan B is approximately $1.15 billion.
Hologic is a developer, manufacturer and supplier of diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women.